DPH Share Price

Open 2070.00 Change Price %
High 2116.00 1 Day 49.00 2.38
Low 2070.00 1 Week 0.00 0.00
Close 2105.00 1 Month -67.00 -3.08
Volume 95789 1 Year 805.00 61.92
52 Week High 2185.00
52 Week Low 1225.00
DPH Important Levels
Resistance 2 2147.64
Resistance 1 2130.07
Pivot 2097.00
Support 1 2079.93
Support 2 2062.36
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
GGP 1.70 -2.86%
GGP 1.70 -2.86%
GGP 1.70 -2.86%
FRR 0.60 7.14%
LLOY 68.74 0.66%
HER 0.04 -20.00%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
HAWK 0.50 100.00%
BAF 72.80 86.67%
BAF 72.80 86.67%
BAF 72.80 86.67%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

Dechra Pharmaceuticals PLC (LON: DPH)

DPH Technical Analysis 4
As on 1st Nov 2017 DPH Share Price closed @ 2105.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1721.82 & Buy for SHORT-TERM with Stoploss of 2026.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
DPH Target for November
1st Target up-side 2138.75
2nd Target up-side 2200.25
3rd Target up-side 2261.75
1st Target down-side 1963.26
2nd Target down-side 1901.75
3rd Target down-side 1840.25
DPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dechra.com
DPH Address
DPH
24 Cheshire Avenue
Cheshire Business Park
Northwich, CW9 7UA
United Kingdom
Phone: 44 1606 814 730
Fax: 44 1606 814 731
DPH Latest News
Interactive Technical Analysis Chart Dechra Pharmaceuticals PLC ( DPH LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dechra Pharmaceuticals PLC
DPH Business Profile
Dechra Pharmaceuticals PLC is engaged in the development, manufacture, distribution, sale, and marketing of veterinary pharmaceuticals worldwide. It markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary professionals in Europe, as well as manufactures products for third party customers. The company also markets and sells a range of endocrine, ophthalmic, dermatological, and equine products in North America. In addition, it develops and licenses its branded veterinary product portfolio of novel and generic pharmaceuticals, and specialist pet diets. The company distributes its products through a mixture of its own direct sales, wholesalers, and national distributor channels. Dechra Pharmaceuticals PLC is headquartered in Northwich, the United Kingdom.